136 related articles for article (PubMed ID: 16815841)
1. Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld.
Jones LL; Brophy SE; Bankovich AJ; Colf LA; Hanick NA; Garcia KC; Kranz DM
J Biol Chem; 2006 Sep; 281(35):25734-44. PubMed ID: 16815841
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
O'Herrin SM; Lebowitz MS; Bieler JG; al-Ramadi BK; Utz U; Bothwell AL; Schneck JP
J Exp Med; 1997 Oct; 186(8):1333-45. PubMed ID: 9334373
[TBL] [Abstract][Full Text] [Related]
3. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
4. Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.
Bowerman NA; Colf LA; Garcia KC; Kranz DM
J Biol Chem; 2009 Nov; 284(47):32551-61. PubMed ID: 19755422
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes.
Speir JA; Garcia KC; Brunmark A; Degano M; Peterson PA; Teyton L; Wilson IA
Immunity; 1998 May; 8(5):553-62. PubMed ID: 9620676
[TBL] [Abstract][Full Text] [Related]
6. A residue in the center of peptide QL9 affects binding to both Ld and the T cell receptor.
Schlueter CJ; Manning TC; Schodin BA; Kranz DM
J Immunol; 1996 Nov; 157(10):4478-85. PubMed ID: 8906825
[TBL] [Abstract][Full Text] [Related]
7. A yeast display system for engineering functional peptide-MHC complexes.
Brophy SE; Holler PD; Kranz DM
J Immunol Methods; 2003 Jan; 272(1-2):235-46. PubMed ID: 12505727
[TBL] [Abstract][Full Text] [Related]
8. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.
Bowerman NA; Crofts TS; Chlewicki L; Do P; Baker BM; Christopher Garcia K; Kranz DM
Mol Immunol; 2009 Sep; 46(15):3000-8. PubMed ID: 19595460
[TBL] [Abstract][Full Text] [Related]
9. Characterization of class I MHC folding intermediates and their disparate interactions with peptide and beta 2-microglobulin.
Smith JD; Solheim JC; Carreno BM; Hansen TH
Mol Immunol; 1995 May; 32(7):531-40. PubMed ID: 7783756
[TBL] [Abstract][Full Text] [Related]
10. A soluble major histocompatibility complex class I peptide-binding platform undergoes a conformational change in response to peptide epitopes.
Rigney E; Kojima M; Glithero A; Elliott T
J Biol Chem; 1998 Jun; 273(23):14200-4. PubMed ID: 9603922
[TBL] [Abstract][Full Text] [Related]
11. The role of an exposed loop in the alpha2 domain in the mouse MHC class I H-2Dd molecule for recognition by the monoclonal antibody 34-5-8S and the NK-cell receptor Ly49A.
Waldenström M; Achour A; Michaelsson J; Rölle A; Kärre K
Scand J Immunol; 2002 Feb; 55(2):129-39. PubMed ID: 11896929
[TBL] [Abstract][Full Text] [Related]
12. Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells.
Hornell TM; Martin SM; Myers NB; Connolly JM
J Immunol; 2001 Oct; 167(8):4207-14. PubMed ID: 11591741
[TBL] [Abstract][Full Text] [Related]
13. Solution mapping of T cell receptor docking footprints on peptide-MHC.
Varani L; Bankovich AJ; Liu CW; Colf LA; Jones LL; Kranz DM; Puglisi JD; Garcia KC
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13080-5. PubMed ID: 17670943
[TBL] [Abstract][Full Text] [Related]
14. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes.
Teng MK; Smolyar A; Tse AG; Liu JH; Liu J; Hussey RE; Nathenson SG; Chang HC; Reinherz EL; Wang JH
Curr Biol; 1998 Mar; 8(7):409-12. PubMed ID: 9545202
[TBL] [Abstract][Full Text] [Related]
15. Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin.
Wang J; Whitman MC; Natarajan K; Tormo J; Mariuzza RA; Margulies DH
J Biol Chem; 2002 Jan; 277(2):1433-42. PubMed ID: 11696552
[TBL] [Abstract][Full Text] [Related]
16. Specificity and binding properties of a single-chain T cell receptor.
Schlueter CJ; Schodin BA; Tetin SY; Kranz DM
J Mol Biol; 1996 Mar; 256(5):859-69. PubMed ID: 8601837
[TBL] [Abstract][Full Text] [Related]
17. Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
Belyakov IM; Kozlowski S; Mage M; Ahlers JD; Boyd LF; Margulies DH; Berzofsky JA
Int Immunol; 2007 Dec; 19(12):1413-20. PubMed ID: 17981793
[TBL] [Abstract][Full Text] [Related]
18. The NK cell MHC class I receptor Ly49A detects mutations on H-2Dd inside and outside of the peptide binding groove.
Matsumoto N; Yokoyama WM; Kojima S; Yamamoto K
J Immunol; 2001 Apr; 166(7):4422-8. PubMed ID: 11254697
[TBL] [Abstract][Full Text] [Related]
19. Amino acid preferences in the octapeptide subunit of the major histocompatibility complex class I heterotrimer H-2Ld.
Pridzun L; Wiesmüller KH; Kienle S; Jung G; Walden P
Eur J Biochem; 1996 Feb; 236(1):249-53. PubMed ID: 8617272
[TBL] [Abstract][Full Text] [Related]
20. Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors.
Jones LL; Colf LA; Bankovich AJ; Stone JD; Gao YG; Chan CM; Huang RH; Garcia KC; Kranz DM
Biochemistry; 2008 Nov; 47(47):12398-408. PubMed ID: 18973345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
